Koob M, Dekant W
Institut für Toxikologie, Universität Würzburg, F.R.G.
Chem Biol Interact. 1991;77(2):107-36. doi: 10.1016/0009-2797(91)90068-i.
Evidence has been accumulating that several classes of compounds are converted by glutathione conjugate formation to toxic metabolites. The aim of this review is to summarize the current knowledge on the biosynthesis and toxicity of glutathione S-conjugates derived from halogenated alkanes, halogenated alkenes, and hydroquinones and quinones. Different types of toxic glutathione conjugates have been identified and will be discussed in detail: (i) conjugates which are transformed to electrophilic sulfur mustards, (ii) conjugates which are converted to toxic metabolites in an enzyme-catalyzed multistep mechanism, (iii) conjugates which serve as a transport form for toxic quinones and (iv) reversible glutathione conjugate formation and release of the toxic agent in cell types with lower glutathione concentrations. The kidney is the main, with some compounds the exclusive, target organ for compounds metabolized by pathways (i) to (iii). Selective toxicity to the kidney is easily explained due to the capability of the kidney to accumulate intermediates formed by processing of S-conjugates and to bioactivate these intermediates to toxic metabolites. The influences of other factors participating in the renal susceptibility are discussed.
越来越多的证据表明,几类化合物通过形成谷胱甘肽缀合物而转化为有毒代谢物。本综述的目的是总结目前关于源自卤代烷烃、卤代烯烃、对苯二酚和醌的谷胱甘肽S-缀合物的生物合成和毒性的知识。已鉴定出不同类型的有毒谷胱甘肽缀合物,并将进行详细讨论:(i) 转化为亲电硫芥的缀合物;(ii) 通过酶催化多步机制转化为有毒代谢物的缀合物;(iii) 作为有毒醌的转运形式的缀合物;以及 (iv) 在谷胱甘肽浓度较低的细胞类型中可逆的谷胱甘肽缀合物形成和有毒剂的释放。肾脏是通过途径 (i) 至 (iii) 代谢的化合物的主要靶器官,某些化合物的唯一靶器官。由于肾脏能够积累由S-缀合物加工形成的中间体并将这些中间体生物活化为有毒代谢物,因此对肾脏的选择性毒性很容易解释。还讨论了其他参与肾脏易感性的因素的影响。